Manae Suzuki Kurokawa

Dr. Manae Suzuki Kurokawa

Disease Biomarker Analysis and Molecular Medicine, Graduate School of Medicine, St. Marianna University, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
MKMasayoshi Katano
Masayoshi Katano
KOKazuki Okamoto
Kazuki Okamoto
MAMitsumi Arito
Mitsumi Arito
YKYuki Kawakami
Yuki Kawakami
MKManae Suzuki Kurokawa
Manae Suzuki Kurokawa
TKTomohiro Kato
Tomohiro Kato
Introduction: In rheumatoid arthritis (RA), synovial fluid (SF) contains a large number of neutrophils that contribute to the inflammation and destruction of the joints. The SF also contains granulocyte-macrophage colony-stimulating factor (GM-CSF), which sustains viability of neutrophils and activates their functions. Using proteomic surveillance, we here tried to elucidate the effects of GM-CSF on neutrophils. Methods: Neutrophils stimulated by GM-CSF were divided into four subcellular fractions: cytosol, membrane/organelle, nuclei, and cytoskeleton. Then, proteins were extracted from each fraction and digested by trypsin. The produced peptides were detected using matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry (MALDI-TOF MS). Results: We detected 33 peptide peaks whose expression was upregulated by more than 2.5-fold in GM-CSF stimulated neutrophils and identified 11 proteins out of the 33 peptides using MALDI-TOF/TOF MS analysis and protein database searches. One of the identified proteins was neutrophil gelatinase-associated lipocalin (NGAL). We confirmed that the level of NGAL in SF was significantly higher in patients with RA than in those with osteoarthritis. We next addressed possible roles of the increased NGAL in RA. We analysed proteome alteration of synoviocytes from patients with RA by treatment with NGAL in vitro. We found that, out of the detected protein spots (approximately 3,600 protein spots), the intensity of 21 protein spots increased by more than 1.5-fold and the intensity of 10 protein spots decreased by less than 1 to 1.5-fold as a result of the NGAL treatment. Among the 21 increased protein spots, we identified 9 proteins including transitional endoplasmic reticulum ATPase (TERA), cathepsin D, and transglutaminase 2 (TG2), which increased to 4.8-fold, 1.5-fold and 1.6-fold, respectively. Two-dimensional electrophoresis followed by western blot analysis confirmed the upregulation of TERA by the NGAL treatment and, moreover, the western blot analysis showed that the NGAL treatment changed the protein spots caused by post-translational modification of TERA. Furthermore, NGAL cancelled out the proliferative effects of fibroblast growth factor (FGF)-2 and epidermal growth factor (EGF) on chondrocytes from a patient with RA and proliferative effect of FGF-2 on chondrosarcoma cells. Conclusions: Our results indicate that GM-CSF contributes to the pathogenesis of RA through upregulation of NGAL in neutrophils, followed by induction of TERA, cathepsin D and TG2 in synoviocytes. NGAL and the upregulated enzymes may therefore play an important role in RA.

27 November 2018 in BMC Rheumatology
Verified
Journal Article
Open access
PDF file
HTHirotaka Tsuno
Hirotaka Tsuno
MAMitsumi Arito
Mitsumi Arito
NSNaoya Suematsu
Naoya Suematsu
TSToshiyuki Sato
Toshiyuki Sato
AHAtsushi Hashimoto
Atsushi Hashimoto
TKTomohiro Kato
Tomohiro Kato
To understand the roles of serum exosomes in rheumatoid arthritis (RA), we comprehensively investigated the protein profiles of serum exosomes in patients with RA. Exosomes were isolated from serum samples obtained from 33 patients (12 with active RA [aRA], 11 with inactive RA [iRA], 10 with osteoarthritis [OA]) and 10 healthy donors (HLs). Proteins extracted from the exosomes were separated by two-dimensional differential gel electrophoresis (2D-DIGE) and identified by mass spectrometry. In total, 204 protein spots were detected by 2D-DIGE. In the aRA, iRA, and OA groups, 24, 5, and 7 spots showed approximately ≥ ±1.3-fold intensity differences compared with the HL group, respectively. We were able to identify proteins in six protein spots. Among them, the protein spot identified as Toll-like receptor 3 (TLR3) showed approximately 6-fold higher intensity in the aRA group than in the other groups. Patients with active RA possessed considerably different protein profiles of serum exosomes from patients with iRA, patients with OA, and healthy donors. The unique protein profile of serum exosomes, such as the possession of abundant TLR3 fragments, may reflect the pathophysiology of active RA.

5 January 2010 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
MHMoriaki Hatsugai
Moriaki Hatsugai
MKManae Suzuki Kurokawa
Manae Suzuki Kurokawa
TKTakefumi Kouro
Takefumi Kouro
KNKohei Nagai
Kohei Nagai
MAMitsumi Arito
Mitsumi Arito
TKTomohiro Kato
Tomohiro Kato

1 January 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TSTaigen Sase
Taigen Sase
MAMitsumi Arito
Mitsumi Arito
HOHidetaka Onodera
Hidetaka Onodera
KOKazuki Omoteyama
Kazuki Omoteyama
MKManae Suzuki Kurokawa
Manae Suzuki Kurokawa
TKTomohiro Kato
Tomohiro Kato

14 July 2010 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
RKR. Karasawa
R. Karasawa
MKManae Suzuki Kurokawa
Manae Suzuki Kurokawa
KYK. Yudoh
K. Yudoh
KMKayo Masuko
Kayo Masuko
SOS. Ozaki
S. Ozaki
TKT. Kato
T. Kato
Anti-endothelial cell antibodies (AECA) have been frequently detected in systemic vasculitis, which affects blood vessels of various sizes. To understand the pathogenic roles of AECA in systemic vasculitis, we attempted to identify target antigens for AECA comprehensively by a proteomic approach. Proteins extracted from human umbilical vein endothelial cells (HUVEC) were separated by two-dimensional electrophoresis, and Western blotting was subsequently conducted using sera from patients with systemic vasculitis. As a result, 53 autoantigenic protein spots for AECA were detected, nine of which were identified by mass spectrometry. One of the identified proteins was peroxiredoxin 2 (Prx2), an anti-oxidant enzyme. Frequency of anti-Prx2 autoantibodies, measured by enzyme-linked immunosorbent assay (ELISA), was significantly higher in systemic vasculitis (60%) compared to those in collagen diseases without clinical vasculitis (7%, P < 0·01) and healthy individuals (0%, P < 0·01). Further, the titres changed in parallel with the disease activity during time–courses. The presence of anti-Prx2 autoantibodies correlated significantly with elevation of serum d-dimers and thrombin–antithrombin complex (P < 0·05). Immunocytochemical analysis revealed that live endothelial cells expressed Prx2 on their surface. Interestingly, stimulation of HUVEC with rabbit anti-Prx2 antibodies increased secretion of interleukin (IL)-6, IL-1β, IL-1ra, growth regulated oncogene (GRO)-α, granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM–CSF), IL-8 and monocyte chemoattractant protein (MCP)-1 more than twofold compared to that of with rabbit immunoglobulin (Ig)G. Taken together, our data suggest that anti-Prx2 autoantibodies would be a useful marker for systemic vasculitis and would be involved in the inflammatory processes of systemic vasculitis.

1 September 2019 in Brain Research
Verified
Journal Article
Closed access
MAMitsumi Arito
Mitsumi Arito
ATAtsuhiro Tsutiya
Atsuhiro Tsutiya
TSTaigen Sase
Taigen Sase
HOHidetaka Onodera
Hidetaka Onodera
TSToshiyuki Sato
Toshiyuki Sato
TKTomohiro Kato
Tomohiro Kato